You are here: Home » News-IANS » Defence-Security
Business Standard

150 Taliban among 180 killed in Afghan airstrikes

War Conflict

IANS  |  Kabul 

As many as 150 Taliban and 30 civilians were killed in airstrikes by the US and Afghan forces on the militant group's drug labs in western Afghanistan, officials said on Monday.

The Sunday raids, which were aimed at choking the militant group's revenue flow from illicit drugs, left 150 suspected Taliban dead, Efe news reported citing the Afghan Ministry of Interior's statement.

Security forces bombed dozens of drug labs run by the militant group in the Bakwa district of Farah province. Militants were processing opium and crystal meth there, it said and added the Taliban were earning $1 million in revenue a day from these drug laboratories.

"In this operation, 68 drug labs were destroyed and 150 Taliban terrorists killed. Another 40 Taliban terrorists were injured," the ministry said.

The operation was carried out on the basis of "accurate and exact coordinates and information of the intelligence with the air support from the foreign forces," it said.

NATO and US forces' authorities in Kabul refused to comment on the operation.

Abdul Rahman Rahmani, deputy spokesperson for the Defence Ministry, confirmed the operation on his Twitter account.

Abdul Ghafoor Mujahid, Governor of Bakwa, however, said there were civilian casualties as well in the operation against drug labs. "All strikes hit the intended targets. But besides Taliban, over 30 civilians were also killed. Among them were six members of a family whose house was located close to a drug lab," Mujahid told Efe news.

Most civilians killed in the operation were working as daily wage labourers in Taliban drug factories and were not members or fighters of the militant group, he said.

Taliban spokesman Qari Yusuf Ahmadi, however, claimed "51 civilians were martyred and 26 injured in airstrikes of the US invaders and their puppets".



(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, May 06 2019. 20:46 IST